Skip to Main Content
Services Talent Knowledge
Site Search
Menu

PressRelease

January 31, 2023

Barclay Damon Welcomes Sara Dorchak

Barclay Damon announces Sara Dorchak, counsel, has joined Barclay Damon’s Trademarks, Copyrights & IP Transactions Practice Area. Her primary office is New York City.

Dorchak has over 10 years of experience in trademark and copyright prosecution and enforcement. She represents domestic and international clients whose businesses span a wide variety of industries, including fashion, entertainment, cannabis, and downloadable and nondownloadable software, among others. Dorchak represents clients before the Trademark Trial and Appeal Board and files documents and trademark applications with the US Patent and Trademark Office. 

In addition to her legal practice, Dorchak is an adjunct professor at St. John’s University School of Law, where she teaches a course on trademark drafting and prosecution. Prior to joining Barclay Damon, Dorchak was an associate at a firm on Long Island, New York.

Barclay Damon attorneys team across offices and practices to provide customized, targeted solutions grounded in industry knowledge and a deep understanding of our clients’ businesses. With nearly 300 attorneys, Barclay Damon is a leading law firm that operates from a strategic platform of offices located in the Northeastern United States and Toronto. For more information, visit our award-winning website at barclaydamon.com.
 

Subscribe

Click here to sign up for alerts, blog posts, and firm news.

Featured Media

Alerts

Website Accessibility Lawsuits: Several "Tester" Plaintiffs—Sandra Ford, Z'Leah Liburd, Livingston Bennett, Brandi Major, and Joshua Espinal—Targeting Businesses in Recent Flurry of Lawsuits

Alerts

Year-End Focus for 403(b) Plan Sponsors: Two Critical Document Deadlines and Typical Year-End Compliance Review

Alerts

Second Circuit Reverses Award of Attorney's Fees in Coverage Dispute Between Liability Insurers

Alerts

Federal Court Narrows Scope of Insurers' Privilege Claims in COVID-19 Coverage Litigation

Alerts

AstraZeneca Escalates FARXIGA® Audit Demands: What Pharmacies Need to Know Now

Alerts

Update on the Evolving Guidance for H-1B Entry Restrictions Under September 19 Presidential Proclamation